Food, Drug & Cosmetic Act

The Federal Food, Drug, and Cosmetic Act (FD&C Act), cited as 21 U.S.C. ch. 9, is a pivotal U.S. law enacted in 1938. It grants the Food and Drug Administration (FDA) the authority to oversee the safety, efficacy, and labeling of foods, drugs, medical devices, and cosmetics. For enterprise risk management, it represents a primary source of compliance risk. Data submitted for pre-market approval, such as clinical trial results and manufacturing processes, constitutes valuable trade secrets. Protecting this data's confidentiality and integrity, often guided by frameworks like ISO/IEC 27001, is crucial to mitigate intellectual property risks during regulatory interactions.

Application involves a three-step process. Step 1: Regulatory Intelligence and Gap Analysis to monitor FDA updates and identify compliance gaps. Step 2: Integrated Compliance Framework, embedding FD&C Act requirements into the Quality Management System (QMS), referencing standards like ISO 13485 for medical devices. Step 3: Submission and Trade Secret Protection Strategy, which involves securing sensitive data in regulatory submissions using controls from ISO/IEC 27001. For example, a Taiwanese biotech firm can reduce FDA inspection findings by over 50% by mapping cGMP (21 CFR Part 211) controls to its internal processes, aiming for a >95% first-pass submission approval rate.

Taiwanese enterprises face three key challenges. 1) Regulatory Complexity: The FDA's requirements differ significantly from Taiwan's TFDA. Solution: Build an expert regulatory affairs team or engage specialized consultants. 2) High Compliance Costs: Meeting cGMP and clinical trial standards is resource-intensive. Solution: Use a phased market-entry strategy and partner with experienced Contract Research/Manufacturing Organizations (CROs/CMOs). 3) Trade Secret Risk: Submitting proprietary data to a foreign agency. Solution: Implement an ISO/IEC 27001 certified Information Security Management System (ISMS) to classify, encrypt, and control access to all submission data. Priority actions include a gap analysis (within 3 months) and establishing a core QMS/ISMS framework (within 9 months).

Winners Consulting specializes in Food, Drug & Cosmetic Act for Taiwan enterprises, delivering compliant management systems within 90 days. Free consultation: https://winners.com.tw/contact